These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 21490323)

  • 1. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.
    Dickerson BC; Stoub TR; Shah RC; Sperling RA; Killiany RJ; Albert MS; Hyman BT; Blacker D; Detoledo-Morrell L
    Neurology; 2011 Apr; 76(16):1395-402. PubMed ID: 21490323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia.
    Bakkour A; Morris JC; Dickerson BC
    Neurology; 2009 Mar; 72(12):1048-55. PubMed ID: 19109536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults.
    Dickerson BC; Wolk DA;
    Neurology; 2012 Jan; 78(2):84-90. PubMed ID: 22189451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical thickness in relation to clinical symptom onset in preclinical AD.
    Pettigrew C; Soldan A; Zhu Y; Wang MC; Moghekar A; Brown T; Miller M; Albert M;
    Neuroimage Clin; 2016; 12():116-22. PubMed ID: 27408796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.
    Putcha D; Brickhouse M; O'Keefe K; Sullivan C; Rentz D; Marshall G; Dickerson B; Sperling R
    J Neurosci; 2011 Nov; 31(48):17680-8. PubMed ID: 22131428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.
    Dickerson BC; Bakkour A; Salat DH; Feczko E; Pacheco J; Greve DN; Grodstein F; Wright CI; Blacker D; Rosas HD; Sperling RA; Atri A; Growdon JH; Hyman BT; Morris JC; Fischl B; Buckner RL
    Cereb Cortex; 2009 Mar; 19(3):497-510. PubMed ID: 18632739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.
    Risacher SL; Saykin AJ; West JD; Shen L; Firpi HA; McDonald BC;
    Curr Alzheimer Res; 2009 Aug; 6(4):347-61. PubMed ID: 19689234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.
    Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM
    JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
    Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
    Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
    Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
    Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
    Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
    JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals.
    Vassilaki M; Christianson TJ; Mielke MM; Geda YE; Kremers WK; Machulda MM; Knopman DS; Petersen RC; Lowe VJ; Jack CR; Roberts RO
    Ann Neurol; 2017 Jun; 81(6):871-882. PubMed ID: 28543731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.
    Racine AM; Touroutoglou A; Abrantes T; Wong B; Fong TG; Cavallari M; Travison TG; Gou Y; Marcantonio ER; Alsop DC; Jones RN; Inouye SK; Dickerson BC;
    J Alzheimers Dis; 2020; 75(1):187-199. PubMed ID: 32250290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
    Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
    Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's-related cortical atrophy is associated with postoperative delirium severity in persons without dementia.
    Racine AM; Fong TG; Travison TG; Jones RN; Gou Y; Vasunilashorn SM; Marcantonio ER; Alsop DC; Inouye SK; Dickerson BC
    Neurobiol Aging; 2017 Nov; 59():55-63. PubMed ID: 28846882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.
    Vemuri P; Wiste HJ; Weigand SD; Shaw LM; Trojanowski JQ; Weiner MW; Knopman DS; Petersen RC; Jack CR;
    Neurology; 2009 Jul; 73(4):287-93. PubMed ID: 19636048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thickness network features for prognostic applications in dementia.
    Raamana PR; Weiner MW; Wang L; Beg MF;
    Neurobiol Aging; 2015 Jan; 36 Suppl 1(Suppl 1):S91-S102. PubMed ID: 25444603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
    Vemuri P; Wiste HJ; Weigand SD; Shaw LM; Trojanowski JQ; Weiner MW; Knopman DS; Petersen RC; Jack CR;
    Neurology; 2009 Jul; 73(4):294-301. PubMed ID: 19636049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.